Jump to main content
図書

Cancer drug discovery and development

Icons representing 図書

Cancer drug discovery and development

Material type
図書
Author
-
Publisher
Humana
Publication date
-
Material Format
Paper
Capacity, size, etc.
-
NDC
-
View All

Notes on use

Note (General):

Humana Press was acquired by Springer Science+Business Media in the fall of 2006 and continues to publish under the Humana Press imprint.

Related materials as well as pre- and post-revision versions

Platinum and other heavy metal compounds in cancer chemotherapy : molecular mechanisms and clinical applicationsLeave the NDL website. COX-2 blockade in cancer prevention and therapyLeave the NDL website. Anticancer drug development guide : preclinical screening, clinical trials, and approvalLeave the NDL website. Proteasome inhibitors in cancer therapyLeave the NDL website. Drug delivery systems in cancer therapyLeave the NDL website. Platinum-based drugs in cancer therapyLeave the NDL website. Matrix metalloproteinase inhibitors in cancer therapyLeave the NDL website. Nucleic acid therapeutics in cancerLeave the NDL website. Cytokines in the genesis and treatment of cancerLeave the NDL website. DNA and histone methylation as cancer targetsLeave the NDL website. Natural killer T cells : balancing the regulation of tumor immunityLeave the NDL website. Advances in DNA repair in cancer therapyLeave the NDL website. Signaling networks and cell cycle control : the molecular basis of cancer and other diseasesLeave the NDL website. Bladder tumors : molecular aspects and clinical managementLeave the NDL website. Apoptosis, senescence, and cancerLeave the NDL website. Gene therapy for cancerLeave the NDL website. Hormone therapy in breast and prostate cancerLeave the NDL website. Cancer drug resistanceLeave the NDL website. Apoptosis and cancer chemotherapyLeave the NDL website. Cell cycle inhibitors in cancer therapy : current strategiesLeave the NDL website. Anticancer drug development guide : preclinical screening, clinical trials, and approvalLeave the NDL website. Tumor targeting in cancer therapyLeave the NDL website. Antiangiogenic agents in cancer therapyLeave the NDL website. Tumor suppressor genes in human cancerLeave the NDL website. Chemoradiation in cancer therapyLeave the NDL website. Antibody-drug conjugates and immunotoxins : from pre-clinical development to therapeutic applicationsLeave the NDL website. Targets for cancer chemotherapy : transcription factors and other nuclear proteinsLeave the NDL website. Molecular targeting in oncologyLeave the NDL website. Hormone therapy in breast and prostate cancerLeave the NDL website. Oncogene-directed therapiesLeave the NDL website. Sensitization of cancer cells for chemo/immuno/radio-therapyLeave the NDL website. Telomeres and telomerase in cancerLeave the NDL website. Promising cancer chemopreventive agentsLeave the NDL website. Macromolecular anticancer therapeuticsLeave the NDL website. Camptothecins in cancer therapyLeave the NDL website. mTOR pathway and mTOR inhibitors in cancer therapyLeave the NDL website. Cancer therapeutics : experimental and clinical agentsLeave the NDL website. Stem cells and cancerLeave the NDL website. Tumor models in cancer researchLeave the NDL website. Genomics and pharmacogenomics in anticancer drug development and clinical responseLeave the NDL website. Histone deacetylases : transcriptional regulation and other cellular functionsLeave the NDL website. Non-Hodgkin lymphoma : prognostic factors and targetsLeave the NDL website. Handbook of cancer vaccinesLeave the NDL website. DNA repair in cancer therapyLeave the NDL website. Nuclear signaling pathways and targeting transcription in cancerLeave the NDL website. Protein tyrosine kinases : from inhibitors to useful drugsLeave the NDL website. Handbook of anticancer pharmacokinetics and pharmacodynamicsLeave the NDL website. The role of microtubules in cell biology, neurobiology, and oncologyLeave the NDL website. Bone metastasis : experimental and clinical therapeuticsLeave the NDL website. Deoxynucleoside analogs in cancer therapyLeave the NDL website.

Search by Bookstore

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

  • CiNii Research

    Search Service
    Paper
    You can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Paper

Material Type
図書
Publication, Distribution, etc.
Alternative Title
CDDD
Place of Publication (Country Code)
us
Target Audience
一般
Note (General)
Humana Press was acquired by Springer Science+Business Media in the fall of 2006 and continues to publish under the Humana Press imprint.
Related Material
Platinum and other heavy metal compounds in cancer chemotherapy : molecular mechanisms and clinical applications
COX-2 blockade in cancer prevention and therapy
Anticancer drug development guide : preclinical screening, clinical trials, and approval
Proteasome inhibitors in cancer therapy
Drug delivery systems in cancer therapy
Platinum-based drugs in cancer therapy
Matrix metalloproteinase inhibitors in cancer therapy
Nucleic acid therapeutics in cancer
Cytokines in the genesis and treatment of cancer
DNA and histone methylation as cancer targets
Natural killer T cells : balancing the regulation of tumor immunity
Advances in DNA repair in cancer therapy
Signaling networks and cell cycle control : the molecular basis of cancer and other diseases
Bladder tumors : molecular aspects and clinical management
Apoptosis, senescence, and cancer
Gene therapy for cancer
Hormone therapy in breast and prostate cancer
Cancer drug resistance
Apoptosis and cancer chemotherapy
Cell cycle inhibitors in cancer therapy : current strategies
Anticancer drug development guide : preclinical screening, clinical trials, and approval
Tumor targeting in cancer therapy
Antiangiogenic agents in cancer therapy
Tumor suppressor genes in human cancer
Chemoradiation in cancer therapy
Antibody-drug conjugates and immunotoxins : from pre-clinical development to therapeutic applications
Targets for cancer chemotherapy : transcription factors and other nuclear proteins
Molecular targeting in oncology
Hormone therapy in breast and prostate cancer
Oncogene-directed therapies
Sensitization of cancer cells for chemo/immuno/radio-therapy
Telomeres and telomerase in cancer
Promising cancer chemopreventive agents
Macromolecular anticancer therapeutics
Camptothecins in cancer therapy
mTOR pathway and mTOR inhibitors in cancer therapy
Cancer therapeutics : experimental and clinical agents
Stem cells and cancer
Tumor models in cancer research
Genomics and pharmacogenomics in anticancer drug development and clinical response
Histone deacetylases : transcriptional regulation and other cellular functions
Non-Hodgkin lymphoma : prognostic factors and targets
Handbook of cancer vaccines
DNA repair in cancer therapy
Nuclear signaling pathways and targeting transcription in cancer
Protein tyrosine kinases : from inhibitors to useful drugs
Handbook of anticancer pharmacokinetics and pharmacodynamics
The role of microtubules in cell biology, neurobiology, and oncology
Bone metastasis : experimental and clinical therapeutics
Deoxynucleoside analogs in cancer therapy
Data Provider (Database)
国立情報学研究所 : CiNii Research